Nishio M, Sawada K, Koizumi K, Tarumi T, Takano H, Endo T, Takashima H, Hashimoto H, Haseyama Y, Kobayashi H, Koike T
Department of Internal Medicine II, Hokkaido University School of Medicine, Sapporo, Japan.
Bone Marrow Transplant. 1998 Dec;22(12):1211-4. doi: 10.1038/sj.bmt.1701508.
Localized cutaneous nontender nodules appeared on the back of a 52-year-old Japanese woman. Skin biopsy revealed atypical large T-lymphocytes infiltrating the dermis. CD30 staining was negative in tumor cells. The diagnosis was CD30-negative cutaneous large T cell lymphoma. There was no evidence of peripheral lymphadenopathy or bone marrow involvement. Six cycles of induction chemotherapy were administered and a complete clinical remission (CCR) was attained. Local irradiation was not given. As the clinical course of CD30-negative cutaneous large T cell lymphoma is recurrent and often incurable with conventional chemoradiotherapy, she received high-dose chemotherapy without total body irradiation (TBI) followed by unpurged autologous peripheral blood stem cell transplantation (APBSCT). A relapse in the skin followed 40 days after APBSCT, but tumor cells transformed into a CD30-positive anaplastic large cell lymphoma (ALCL). We question the need for TBI in conditioning and for purged stem cells for APBSCT in patients with high risk cutaneous lymphomas.
一名52岁的日本女性背部出现局限性皮肤无痛性结节。皮肤活检显示非典型大T淋巴细胞浸润真皮。肿瘤细胞CD30染色阴性。诊断为CD30阴性皮肤大T细胞淋巴瘤。没有外周淋巴结病或骨髓受累的证据。给予六个周期的诱导化疗,达到了完全临床缓解(CCR)。未进行局部放疗。由于CD30阴性皮肤大T细胞淋巴瘤的临床病程易复发,且传统放化疗往往无法治愈,她接受了无全身照射(TBI)的大剂量化疗,随后进行了未净化的自体外周血干细胞移植(APBSCT)。APBSCT后40天皮肤复发,但肿瘤细胞转化为CD30阳性间变性大细胞淋巴瘤(ALCL)。我们质疑高危皮肤淋巴瘤患者在预处理中进行TBI以及在APBSCT中使用净化干细胞的必要性。